drug protocol number

DIM-05762

drug sponsor

ervier Affaires Médicales

drug study

SodiumGlucose Co-transporter 2 Inhibitor added to Gliclazide Modified Release

drug trial site

King Khalid University Hospital (Riyadh),King Abdulaziz University Hospital (Jeddah),Ghassan Najeeb Pharaon hospital (Jeddah)

drug status

Ongoing

drug phase